JP5633028B2 - 交感神経活発化剤 - Google Patents
交感神経活発化剤 Download PDFInfo
- Publication number
- JP5633028B2 JP5633028B2 JP2013143531A JP2013143531A JP5633028B2 JP 5633028 B2 JP5633028 B2 JP 5633028B2 JP 2013143531 A JP2013143531 A JP 2013143531A JP 2013143531 A JP2013143531 A JP 2013143531A JP 5633028 B2 JP5633028 B2 JP 5633028B2
- Authority
- JP
- Japan
- Prior art keywords
- black ginger
- sympathetic nerve
- administration
- extract
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002889 sympathetic effect Effects 0.000 title claims description 23
- 210000005036 nerve Anatomy 0.000 title claims description 16
- 239000012190 activator Substances 0.000 title claims description 11
- 241000234314 Zingiber Species 0.000 claims description 32
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 32
- 235000008397 ginger Nutrition 0.000 claims description 32
- 230000036760 body temperature Effects 0.000 claims description 2
- 230000037396 body weight Effects 0.000 claims description 2
- 230000001079 digestive effect Effects 0.000 claims description 2
- 230000028327 secretion Effects 0.000 claims description 2
- 230000002496 gastric effect Effects 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 37
- 239000003795 chemical substances by application Substances 0.000 description 17
- 239000000284 extract Substances 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- 239000002775 capsule Substances 0.000 description 10
- 239000008187 granular material Substances 0.000 description 10
- 230000008035 nerve activity Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 229940002508 ginger extract Drugs 0.000 description 9
- 235000020708 ginger extract Nutrition 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 210000003486 adipose tissue brown Anatomy 0.000 description 7
- 210000001198 duodenum Anatomy 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000007901 soft capsule Substances 0.000 description 7
- 238000001035 drying Methods 0.000 description 6
- 230000002183 duodenal effect Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 210000002820 sympathetic nervous system Anatomy 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- 210000000467 autonomic pathway Anatomy 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000395050 Kaempferia parviflora Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013143531A JP5633028B2 (ja) | 2012-07-10 | 2013-07-09 | 交感神経活発化剤 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012154966 | 2012-07-10 | ||
JP2012154966 | 2012-07-10 | ||
JP2013143531A JP5633028B2 (ja) | 2012-07-10 | 2013-07-09 | 交感神経活発化剤 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014151767A Division JP6355248B2 (ja) | 2012-07-10 | 2014-07-25 | 交感神経活発化剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014031367A JP2014031367A (ja) | 2014-02-20 |
JP5633028B2 true JP5633028B2 (ja) | 2014-12-03 |
Family
ID=50281502
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013143531A Active JP5633028B2 (ja) | 2012-07-10 | 2013-07-09 | 交感神経活発化剤 |
JP2013143532A Active JP5928732B2 (ja) | 2012-07-10 | 2013-07-09 | 褐色脂肪細胞活発化剤 |
JP2014151767A Active JP6355248B2 (ja) | 2012-07-10 | 2014-07-25 | 交感神経活発化剤 |
JP2014202055A Active JP6211500B2 (ja) | 2012-07-10 | 2014-09-30 | 褐色脂肪細胞活発化剤 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013143532A Active JP5928732B2 (ja) | 2012-07-10 | 2013-07-09 | 褐色脂肪細胞活発化剤 |
JP2014151767A Active JP6355248B2 (ja) | 2012-07-10 | 2014-07-25 | 交感神経活発化剤 |
JP2014202055A Active JP6211500B2 (ja) | 2012-07-10 | 2014-09-30 | 褐色脂肪細胞活発化剤 |
Country Status (1)
Country | Link |
---|---|
JP (4) | JP5633028B2 (enrdf_load_stackoverflow) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5845526B2 (ja) * | 2014-05-14 | 2016-01-20 | 株式会社東洋新薬 | 黒生姜を含有する水溶性組成物 |
JP5849272B1 (ja) * | 2014-09-10 | 2016-01-27 | 株式会社東洋新薬 | 黒生姜含有PPARγ発現促進組成物 |
JP6447972B2 (ja) * | 2015-05-07 | 2019-01-09 | 株式会社東洋新薬 | 黒生姜含有PPARγ発現促進組成物 |
JP6765090B2 (ja) * | 2019-05-14 | 2020-10-07 | 株式会社東洋新薬 | 黒生姜含有組成物 |
JP7081843B2 (ja) * | 2020-10-26 | 2022-06-07 | 株式会社東洋新薬 | 自律神経調節剤 |
WO2024105922A1 (ja) * | 2022-11-18 | 2024-05-23 | プレミアアンチエイジング株式会社 | 抗肥満用、体脂肪減少用又は脂肪代謝促進用組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007097547A (ja) * | 2005-10-07 | 2007-04-19 | Chiba Univ | 肥満治療剤または肥満予防剤のスクリーニング方法 |
JP2009051790A (ja) * | 2007-08-29 | 2009-03-12 | Maruzen Pharmaceut Co Ltd | 抗酸化剤、抗老化剤、抗炎症剤、育毛剤、抗肥満剤、及び美白剤、並びに化粧料及び美容用飲食品 |
JP2009067731A (ja) * | 2007-09-14 | 2009-04-02 | Office K:Kk | 冷え性改善用組成物 |
-
2013
- 2013-07-09 JP JP2013143531A patent/JP5633028B2/ja active Active
- 2013-07-09 JP JP2013143532A patent/JP5928732B2/ja active Active
-
2014
- 2014-07-25 JP JP2014151767A patent/JP6355248B2/ja active Active
- 2014-09-30 JP JP2014202055A patent/JP6211500B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP6211500B2 (ja) | 2017-10-11 |
JP2014031368A (ja) | 2014-02-20 |
JP2014240442A (ja) | 2014-12-25 |
JP2014198732A (ja) | 2014-10-23 |
JP5928732B2 (ja) | 2016-06-01 |
JP2014031367A (ja) | 2014-02-20 |
JP6355248B2 (ja) | 2018-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6064156B2 (ja) | 深部体温上昇剤 | |
JP5633028B2 (ja) | 交感神経活発化剤 | |
CN101731630A (zh) | 一种具有解酒、护肝功效的保健食品 | |
JP2010209051A (ja) | 脂肪吸収抑制剤 | |
US10111451B2 (en) | Food, beverage or pharmaceutical composition containing fermented eastern prickly pear and a preparation method therefor | |
CN102771593A (zh) | 一种降血糖、血脂、血压的藤茶制剂及其制备方法 | |
JP3988168B1 (ja) | イチョウ葉エキスナノ微粒子による脳細胞活性効果を有する組成物 | |
JP2015027998A (ja) | 保湿剤、皮膚バリア機能改善剤、タイトジャンクション形成促進剤、trpv4発現上昇剤、細胞内カルシウム濃度上昇剤、細胞内カルシウム濃度上昇剤、脂質合成促進剤、血流改善剤及びクマ改善剤 | |
KR20220112888A (ko) | 금화규 유래 콜라겐아미노산을 이용한 기능성 콜라겐 조성물 | |
JP2016160198A (ja) | 黒生姜含有組成物 | |
JPH09208484A (ja) | 活性酸素消去剤及びそれを含む組成物 | |
JP6765090B2 (ja) | 黒生姜含有組成物 | |
KR101964249B1 (ko) | 사상자 추출물 및 카퍼트리펩타이드-1 혼합물을 유효성분으로 함유하는 아토피 피부염의 예방, 개선 또는 치료용 조성물 | |
EP4205558A1 (en) | Health functional food, comprising siberian chrysanthemum extract, for pain relief or antioxidation | |
KR102209663B1 (ko) | 조팝나무 추출물을 포함하는 피부질환 예방 또는 치료용 조성물 | |
KR20170100100A (ko) | 상백피(Morus alba Linne) 추출물을 포함하는 전립선 비대증의 예방 또는 치료용 조성물 | |
WO2008069604A1 (en) | Composition comprising the mixed herbal extract of aralia cordata thunb. and cimicifuga heracleifolia kom. for preventing and treating inflammatory disease and pain disease | |
CN108653716A (zh) | 一种茶叶精华解酒片及其制备方法 | |
JP7228544B2 (ja) | 有効成分としてヤブラン(Liriope platyphylla)の抽出物を含む、ニコチン中毒の予防又は治療用の組成物 | |
JP2007182403A (ja) | 抗アレルギー剤 | |
JP2016210703A (ja) | 時計遺伝子発現促進用組成物 | |
JP6926378B2 (ja) | マイクロダスト貪食促進剤 | |
KR102209664B1 (ko) | 회잎나무 추출물을 포함하는 피부질환 예방 또는 치료용 조성물 | |
JP2020193230A (ja) | 黒生姜含有組成物 | |
KR20150051710A (ko) | 자단향 추출물을 유효성분으로 함유하는 알레르기성 질환 예방 또는 치료용 약학적 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20131212 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20131212 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20140115 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140128 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140313 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140331 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140624 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140725 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20140825 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140916 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140917 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5633028 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |